Researchers from CHOP and Penn are working to perfect 3D models of GI disease and create more personalized treatments for patients.

Regional and local differences in the diagnosis and treatment of celiac disease affects outcomes for youth.

CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.

If your child is complaining about regular belly pain, constipation, nausea or diarrhea, it’s time to talk to your pediatrician.

Research in the lab and at the bedside offer new hope for young patients with biliary atresia, Alagille syndrome and other chronic liver disorders.

Active research at the Fred and Suzanne Biesecker Pediatric Liver Center.

Bench-to-bedside research supports GI innovation at CHOP.

Personalized therapeutic approaches for children with eosinophilic esophagitis are gaining ground at CHOP.

Game-changing treatments for pediatric IBD patients come after care is streamlined and new uses for existing medications is explored.

Case: A 7-month-old male presented to one of Children’s Hospital of Philadelphia’s After-hours Urgent Care locations with vomiting, dry heaves, and lethargy. It was his third similar episode.